Table 4 CSF ELISA testing of patients (DCM) >  < 6 month.

From: Decreased angiogenesis as a possible pathomechanism in cervical degenerative myelopathy

CSF ELISA testing

DCM > 6 month

DCM < 6 month

P*

ηp2

M [SD]

M [SD]

Angiogenic mediators

N = 13

N = 9

  

 Angiopoietin 2 (pg/ml)

250.0 [85.3]

275.8 [76.3]

.52

.02

 VEGF C (pg/ml)

162.0 [103.6]

149.2 [97.8]

.69

.01

 VEGF A (pg/ml)

15.6 [9.8]

14.4 [7.5]

.73

.01

Inflammatory mediators

N = 11

N = 8

  

 IL1 beta (pg/ml)

.8 [.4]

3.2 [7.6]

.35

.06

 IL 8 (pg/ml)

72.3 [95.8]

69.3 [50.5]

.90

.00

 Rantes (pg/ml)

5.3 [13.7]

0.8 [.6]

.33

.06

  1. CSF cerebrospinal fluid, DCM degenerative cervical myelopathy, pg/ml picogram per milliliter, M mean, SD standard deviation, TAAA thoracic-abdominal aortic aneurysm.
  2. *p values reflect the univariate post-hoc between group tests revealed by the MANOVAs; ηp2 = partial eta squared effect size.
  3. Italic values indicate significance level of p < .05.
Back to article page